⁶⁸Ga-FAPI PET/CT in cardiac Anderson–Fabry disease: novel insights into disease assessment from a case series
Anderson–Fabry disease (AFD) is an X-linked lysosomal disorder in which cardiac involvement is the main cause of morbidity and mortality, manifesting as left ventricular hypertrophy, heart failure, arrhythmias, and myocardial fibrosis. Myocardial fibrosis is a key pathophysiological process associated with an adverse prognosis. While cardiac magnetic resonance (CMR) identifies established myocardial fibrosis, fibroblast activation protein inhibitor (FAPI) PET enables the molecular assessment of FAP-associated activity. By complementing conventional CMR parameters, including late gadolinium enhancement and native T1 mapping, FAPI PET may improve the characterization and phenotypic classification of cardiac involvement in Anderson–Fabry disease. We report three cases of AFD patients, who underwent Gallium-68–fibroblast activation protein inhibitor (⁶⁸Ga-FAPI) PET-CT as part of a prospective study designed to assess myocardial fibrosis. Overall, ⁶⁸Ga-FAPI uptake closely correlated with CMR findings, reinforcing the role of cardiac fibroblast activation as a relevant pathogenic mechanism in AFD. These findings highlight this new molecular imaging as a promising tool for early detection, risk stratification, and therapeutic guidance in AFD.
Authors
- Catarina Marques (ORCID: https://orcid.org/0000-0002-8958-2961)
- Elisabete Martins (ORCID: https://orcid.org/0000-0002-6944-2953)
- Paula Soeiro (ORCID: https://orcid.org/0000-0002-7692-0343)
- Teresa Faria (ORCID: https://orcid.org/0000-0002-9581-9830)
- Inês Fortuna (ORCID: https://orcid.org/0000-0002-7010-2104)
- Janete Santos
- Ana Oliveira (ORCID: https://orcid.org/0009-0003-8120-3378)
- João Paulo Oliveira
- Helena Moreira
- Mariana Vasconcelos
Publication Details
- Journal
- EJNMMI Reports
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1186/s41824-026-00337-0
- Primary Topic
- Lysosomal Storage Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00